These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3296351)

  • 21. Hemodynamic responses in brain dead organ donor patients.
    Wetzel RC; Setzer N; Stiff JL; Rogers MC
    Anesth Analg; 1985 Feb; 64(2):125-8. PubMed ID: 3882020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and oxygen transport patterns after head trauma and brain death: implications for management of the organ donor.
    Belzberg H; Shoemaker WC; Wo CC; Nicholls TP; Dang AB; Zelman V; Gruen JP; Berne TV; Demetriades D
    J Trauma; 2007 Nov; 63(5):1032-42. PubMed ID: 17993948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic inflammation in the brain-dead organ donor.
    Barklin A
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):425-35. PubMed ID: 19226294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of posttraumatic donor's disseminated intravascular coagulation in intrathoracic organ donation and transplantation.
    Valdivia M; Chamorro C; Romera MA; Balandín B; Pérez M
    Transplant Proc; 2007 Sep; 39(7):2427-8. PubMed ID: 17889210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal effects of parenteral fish oil administered to heart-beating organ donors and renal-transplant recipients: a tolerance study.
    Singer P; Zolotarski V; Yussim A; Lustig S; Attal-Singer J; Cohen J
    Clin Nutr; 2004 Aug; 23(4):597-603. PubMed ID: 15297096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A valid experimental brain death organ donor model.
    Bittner HB; Kendall SW; Campbell KA; Montine TJ; Van Trigt P
    J Heart Lung Transplant; 1995; 14(2):308-17. PubMed ID: 7779850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric organ donor maintenance: pathophysiologic derangements and nursing requirements.
    Kissoon N; Frewen TC; Bloch M; Gayle M; Stiller C
    Pediatrics; 1989 Oct; 84(4):688-93. PubMed ID: 2780131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of hormonal treatment with triiodothyronine and cortisone in brain dead patients].
    Mariot J; Jacob F; Voltz C; Perrier JF; Strub P
    Ann Fr Anesth Reanim; 1991; 10(4):321-8. PubMed ID: 1928853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the brain death related endocrine dysfunction an indication for hormonal substitution therapy in the early period ?
    Hagl C; Szabó G; Sebening C; Tochtermann U; Vahl CF; Sonnenberg K; Hagl S
    Eur J Med Res; 1997 Oct; 2(10):437-40. PubMed ID: 9348271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-heart-beating organ donors as a source of kidneys for transplantation: a chart review.
    Campbell GM; Sutherland FR
    CMAJ; 1999 Jun; 160(11):1573-6. PubMed ID: 10373998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using thyroid hormone in brain-dead donors to maximize the number of organs available for transplantation.
    Salim A; Martin M; Brown C; Inaba K; Roth B; Hadjizacharia P; Mascarenhas A; Rhee P; Demetriades D
    Clin Transplant; 2007; 21(3):405-9. PubMed ID: 17488392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone levels, hemodynamics, and metabolism in brain dead organ donors.
    Mariot J; Sadoune LO; Jacob F; Dousset B; Perrier JF; Jacob C; Strub P; Voltz C
    Transplant Proc; 1995 Feb; 27(1):793-4. PubMed ID: 7879187
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of various donor factors on primary and long-term function of the transplanted kidney].
    Koller J; Wieser C; Kornberger R; Gottardis M; Ofner D; Margreiter R
    Wien Klin Wochenschr; 1993; 105(15):425-8. PubMed ID: 8379154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gradual onset brain death model: a relevant model to study organ donation and its consequences on the outcome after transplantation.
    Kolkert JL; 't Hart NA; van Dijk A; Ottens PJ; Ploeg RJ; Leuvenink HG
    Lab Anim; 2007 Jul; 41(3):363-71. PubMed ID: 17640464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique.
    Wheeldon DR; Potter CD; Oduro A; Wallwork J; Large SR
    J Heart Lung Transplant; 1995; 14(4):734-42. PubMed ID: 7578183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Donor heart preservation].
    Hayashi Y; Iwasaki M
    Masui; 2008 Jan; 57(1):60-8. PubMed ID: 18214006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonheart-beating donors: the Maastricht experience.
    Daemen JW; Kootstra G; Wijnen RM; Yin M; Heineman E
    Clin Transpl; 1994; ():303-16. PubMed ID: 7547551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of free radicals: mediated injury occurring in the kidney donor.
    Kosieradzki M; Kuczynska J; Piwowarska J; Wegrowicz-Rebandel I; Kwiatkowski A; Lisik W; Michalak G; Danielewicz R; Paczek L; Rowinski WA
    Transplantation; 2003 Apr; 75(8):1221-7. PubMed ID: 12717206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative hemodynamic heterogeneity of brain dead organ donors.
    Duke PK; Ramsay MA; Paulsen AW; Gunning TC; Roberts LC; Swygert TH; Valek TR
    Transplant Proc; 1991 Oct; 23(5):2485-6. PubMed ID: 1926444
    [No Abstract]   [Full Text] [Related]  

  • 40. Organ protective management of the brain-dead donor.
    Saner FH; Kavuk I; Lang H; Radtke A; Paul A; Broelsch CE
    Eur J Med Res; 2004 Oct; 9(10):485-90. PubMed ID: 15546816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.